Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
02/2012
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102361853A Toluidine sulfonamides and their use
02/21/2012US8119673 Compounds 148
02/21/2012US8119672 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/15/2012EP1963259B1 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
02/15/2012EP1877389B1 Synthesis of cyclen derivatives
02/15/2012CN102351805A Method for preparing, separating and refining 5-amino-1H-tetrazol-1-ylacetic acid
02/15/2012CN102351804A Method for recovering valsartan racemate
02/15/2012CN101812029B Method for producing 5-halogenolinear alkyl tetrazole
02/14/2012US8114863 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
02/09/2012WO2012016969A1 Highly crystalline valsartan
02/09/2012CA2806657A1 Highly crystalline valsartan
02/08/2012CN102010381B 一种缬沙坦制备方法的改进 Improve one method for preparing Valsartan
02/08/2012CN101376637B 高立方烷二酰胺类化合物及其应用 High cubane diamide compound classes and their applications
02/07/2012CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic
02/02/2012US20120029177 Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof
02/01/2012EP2412789A1 Lubricant composition and use thereof
02/01/2012EP1817301B1 Potentiators of glutamate receptors
02/01/2012CN102341378A Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives
01/2012
01/31/2012US8106216 Process for the preparation of Irbesartan
01/31/2012US8106082 Dual-acting antihypertensive agents
01/26/2012WO2012012612A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
01/26/2012US20120022268 New Salt Hydrates
01/26/2012US20120021253 Lubricant composition and use thereof
01/26/2012US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System
01/25/2012EP2408755A2 Psma-targeting compounds and uses thereof
01/25/2012CN102329306A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension
01/25/2012CN102329276A Method for recovering valsartan mother liquid
01/24/2012US8101642 3-substituted propanamine compounds
01/24/2012US8101599 Pharmaceutical composition containing anti-hypertensive agents
01/19/2012WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/19/2012WO2011102626A3 Polyazamacrocyclic compound, and a production method and a biomedical use therefor
01/19/2012US20120015990 Taspase1 inhibitors and their uses
01/19/2012US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists
01/18/2012EP2407461A1 Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives
01/18/2012CN102321039A Synthesis of electronic chemical 5-amino tetrazole
01/18/2012CN102321038A Improved valsartan preparation method
01/18/2012CN101805305B 5-(2 nitro-methylene)-MTT and preparation method and application thereof
01/12/2012WO2012004604A1 Tetrazole compounds as calcium channel blockers
01/12/2012US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
01/12/2012US20120009121 Psma-targeting compounds and uses thereof
01/12/2012US20120007026 Tetrazine monomers and copolymers for use in organic electronic devices
01/11/2012EP2404890A1 Hydroxyl compounds and compositions for cholesterol management and related uses
01/10/2012CA2455559C Methods to mobilize progenitor/stem cells
01/05/2012WO2012003031A2 Alternative to tetrazene
01/05/2012WO2012002189A1 Method for producing valsartan
01/05/2012WO2012001694A1 Process for olmesartan medoxomil
01/05/2012WO2012001484A2 An improved process for the preparation of valsartan
01/05/2012US20120004420 Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives
01/05/2012US20120004419 Bis-(1(2)h-tetrazol-5-yl) amine and production method therefor
01/04/2012EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses
01/04/2012EP1339663B1 Naphthalene derivatives
01/04/2012CN102307847A Indanyl compounds
01/03/2012US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/2011
12/29/2011WO2011161945A1 Alkoxyimino derivative and pest control agent
12/29/2011WO2011161076A1 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives
12/29/2011US20110319438 Novel sulfonamides as l-cpt1 inhibitors
12/29/2011US20110319359 Indanyl compounds
12/28/2011CN102295617A 一种电子化学品5-氨基四氮唑的精制和提纯方法 Refining and purification method of electronic chemicals 5-amino-tetrazole
12/27/2011US8084619 Gas generant compositions
12/27/2011US8084498 Ketone compounds and compositions for cholesterol management and related uses
12/27/2011US8084467 Pyrazole derivatives as cannabinoid receptor antagonists
12/21/2011EP2396301A2 Small molecule bradykinin b1 receptor antagonists
12/21/2011EP2217580B1 Substituted tetrazole compounds and uses thereof
12/20/2011CA2450221C Compounds for the treatment of metabolic disorders
12/15/2011WO2011156655A2 Novel glp-1 receptor stabilizers and modulators
12/15/2011US20110306768 Processes for the manufacture of 3--pyridine, 4-methyl-3-methylthio-5-(3-pyridyl)-l,2,4-triazole, and (1r)-1-[2-(3-methylphenyl)-2h-tetrazol-5-yl]ethanol
12/15/2011US20110306542 Novel glp-1 receptor stabilizers and modulators
12/15/2011US20110305666 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
12/14/2011EP1893582B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders
12/13/2011US8076492 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
12/13/2011US8076330 Dipeptidyl peptidase-IV inhibitors
12/08/2011WO2011151683A1 Zn (ii) based colorimetric sensor and process for the preparation thereof
12/08/2011WO2011151347A1 Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole
12/08/2011US20110301196 Trypsin-like serine protease inhibitors, and their preparation and use
12/08/2011US20110301180 Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration
12/08/2011DE102010023105A1 Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol Gadobutrolherstellung one-pot method using DMF acetal and N-methylimidazole
12/08/2011CA2801255A1 Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole
12/07/2011EP2391610A1 Luminescent lanthanide complexes
12/07/2011CN102272109A 血管内造影剂 Intravascular contrast agent
12/07/2011CN101239935B 酞菁化合物及其中间体的制备方法以及这些中间体化合物 Phthalocyanine compounds and intermediates for preparing compounds and intermediates
12/06/2011US8071784 Lead-free primary explosive composition and method of preparation
12/01/2011US20110293553 Identification of insect attractant, arresting, and/or aggregation compounds and methods thereof
11/2011
11/30/2011EP2389367A1 Preparation of a lead-free primary explosive
11/23/2011CN102256967A Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy] -4h- [1,2, 4] triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5
11/23/2011CN102250031A High-purity valsartan compound
11/22/2011US8063228 Conversion of salt halides to nitrate salts
11/22/2011US8063082 Certain chemical entities, compositions, and methods
11/22/2011US8063032 Histamine H3 inverse agonists and antagonists and methods of use thereof
11/17/2011WO2011142124A1 Photoresponsive liquid crystal compound and use thereof
11/17/2011US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011US20110281795 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
11/17/2011US20110280802 Linkers For Radiopharmaceutical Compounds
11/17/2011DE102010020652A1 New compound having tetrazine anion comprising 1,2,4,5-tetrazine-3,6-bis(thiolate) or 3-mercapto-6-sulfido-3H-1,2,4, 5-tetrazin-2-ide, useful e.g. for producing 1,6-dihydro-(1,2,4,5)tetr azine-3,6-dithiol derivative
11/16/2011CN102245583A Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
11/16/2011CN102241640A Synthesis method of tris-(4-tetrazolyl-phenyl)amine
11/15/2011US8058301 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
11/15/2011CA2549995C Ketone compounds and compositions for cholesterol management and related uses
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 97